Earnings Feed
Start Free
Inozyme Pharma, Inc.·4

May 20, 4:00 PM ET

Bolte Axel 4

4 · Inozyme Pharma, Inc. · Filed May 20, 2025

Insider Transaction Report

Form 4
Period: 2025-05-15
Inozyme Pharma, Inc.INZY
Bolte Axel
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2025-05-15$0.98/sh+152,823$149,767→ 419,519 total
  • Exercise/Conversion

    Common Stock

    2025-05-15$0.98/sh+4,407$4,319→ 423,926 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-05-15−152,823→ 0 total
    Exercise: $0.98Exp: 2027-06-27→ Common Stock (152,823 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-05-15−4,407→ 0 total
    Exercise: $0.98Exp: 2027-06-27→ Common Stock (4,407 underlying)
Footnotes (1)
  • [F1]These options are fully vested.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4